Volpara Health Technologies Performance

VPAHFDelisted Stock  USD 0.74  0.00  0.00%   
The entity has a beta of 0.41, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Volpara Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Volpara Health is expected to be smaller as well. Volpara Health Techn right now has a risk of 0.0%. Please validate Volpara Health value at risk, as well as the relationship between the kurtosis and day typical price , to decide if Volpara Health will be following its existing price patterns.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Volpara Health Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Volpara Health is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow7.2 M
Total Cashflows From Investing Activities13.2 M
  

Volpara Health Relative Risk vs. Return Landscape

If you would invest  74.00  in Volpara Health Technologies on September 19, 2024 and sell it today you would earn a total of  0.00  from holding Volpara Health Technologies or generate 0.0% return on investment over 90 days. Volpara Health Technologies is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Volpara, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  

Volpara Health Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Volpara Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Volpara Health Technologies, and traders can use it to determine the average amount a Volpara Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
VPAHF
Based on monthly moving average Volpara Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Volpara Health by adding Volpara Health to a well-diversified portfolio.

Volpara Health Fundamentals Growth

Volpara Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Volpara Health, and Volpara Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Volpara Pink Sheet performance.

About Volpara Health Performance

By analyzing Volpara Health's fundamental ratios, stakeholders can gain valuable insights into Volpara Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Volpara Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Volpara Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company was incorporated in 2009 and is headquartered in Wellington, New Zealand. Volpara Health operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 189 people.

Things to note about Volpara Health Techn performance evaluation

Checking the ongoing alerts about Volpara Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Volpara Health Techn help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Volpara Health Techn is not yet fully synchronised with the market data
Volpara Health Techn has some characteristics of a very speculative penny stock
Volpara Health Techn has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 24.27 M. Net Loss for the year was (16.44 M) with profit before overhead, payroll, taxes, and interest of 23.82 M.
Volpara Health Technologies has accumulated about 18.14 M in cash with (11.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07.
Roughly 25.0% of the company outstanding shares are owned by insiders
Evaluating Volpara Health's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Volpara Health's pink sheet performance include:
  • Analyzing Volpara Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Volpara Health's stock is overvalued or undervalued compared to its peers.
  • Examining Volpara Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Volpara Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Volpara Health's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Volpara Health's pink sheet. These opinions can provide insight into Volpara Health's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Volpara Health's pink sheet performance is not an exact science, and many factors can impact Volpara Health's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Consideration for investing in Volpara Pink Sheet

If you are still planning to invest in Volpara Health Techn check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Volpara Health's history and understand the potential risks before investing.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Money Managers
Screen money managers from public funds and ETFs managed around the world